搜索医生

Phillip H. Kuo, M.D., Ph.D.

预约门诊

出版物

  1. Zaidi S, Kuo PH, Paiva Prudente T, Lacuna KP, Babiker HM, Aparicio R, Schonhoft JD, Fernandez L, Messmann R, Groaning M, Tolcher AW, Gordon MS, Yoo DC, Vaishampayan U, Picus J, Petrylak DP, Sartor O, Morris MJ. Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169. Clin Cancer Res. 2026 May 1; 32 (9):1766-1776
    View PubMed
  2. Nordquist LT, Andrews JR, Kuo PH, Gartrell BA, Josephson D, Purysko AS, Saltzstein DR, Pathak RA, Shore N, Sykes J, Penny R, Davis P, Helfand BT. An intra-patient contemporaneous comparison of (18)F-piflufolastat and (18)F-flotufolastat urinary radioactivity and pelvic region detection rates in men with low PSA biochemical recurrence of prostate cancer after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2026 May; 53 (6):3529-3541 Epub 2026 Feb 23
    View PubMed
  3. Armstrong AJ, Morris MJ, Abida W, Aggarwal RR, Antonarakis ES, Attard G, Beltran H, Bryce A, Carducci MA, Cheng HH, Chen DL, Chi KN, Childs DS, Dahut W, Emmett L, Fizazi K, Gafita A, George DJ, Hermann K, Hofman MS, Hope T, Hussain M, Kelly WK, Kessler E, Kuo PH, Lang J, Liu G, Marshall CH, Morgans AK, McKay RR, Nanus D, Nelson P, Paller C, Reichert ZR, Ryan CJ, Sartor AO, Schoder H, Schwartz LH, Sharifi N, Stadler WM, Stein M, Sternberg CN, Szmulewitz RZ, Tagawa ST, Sokolova AO, Wyatt AW, Yamoah K, Yu EY, Halabi S, Scher HI, PCWG4 Writing Group. Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4. J Clin Oncol. 2026 May; 44 (13):1249-1265 Epub 2026 Feb 26
    View PubMed
  4. Rajiah PS, Hanneman K, Allen BD, Crowe C, El-Sherief AH, Hamzeh I, Hsu JY, Kuo PH, Lenge de Rosen V, Lopez-Mattei JC, Parwani P, Renapurkar RD, Tandon S, Bolen MA, Expert Panel on Cardiac Imaging. ACR Appropriateness Criteria(R) Evaluation of Cardiac Masses. J Am Coll Radiol. 2026 Apr; 23 (4):637-657 Epub 2026 Feb 20
    View PubMed
  5. Nasrallah IM, Kuo PH, Nordberg A, Bohnen NI, Ponisio MR. The Impact of Amyloid and Tau PET on Alzheimer Disease Diagnostics: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2025 Nov; 225 (5):e2432325 Epub 2025 Apr 16
    View PubMed
  6. Kuo PH, Calais J, Crosby M. PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand Therapy. Target Oncol. 2025 Jul; 20 (4):597-613 Epub 2025 May 26
    View PubMed
  7. Rabinovici GD, Knopman DS, Arbizu J, Benzinger TLS, Donohoe KJ, Hansson O, Herscovitch P, Kuo PH, Lingler JH, Minoshima S, Murray ME, Price JC, Salloway SP, Weber CJ, Carrillo MC, Johnson KA. Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup. J Nucl Med. 2025 Jun 6; 66 (Suppl 2):S5-S31 Epub 2025 June 06
    View PubMed
  8. Kalluri KS, Zeraatkar N, Auer B, Pells S, Pretorius PH, Richards GR, May M, Momsen N, Doty K, Gonzales MR, Fromme T, Truong K, Kupinski MA, Kuo PH, Furenlid LR, King MA. Examination of aperture layout designs for an adaptive-stationary multi-pinhole brain-dedicated SPECT system. Med Phys. 2025 Jun; 52 (6):3734-3759 Epub 2025 May 11
    View PubMed
  9. Soderlund KA, Austin MJ, Ben-Haim S, Chu S, Ivanidze J, Joshi P, Kalnins A, Kennedy M, Kulshreshtha A, Kuo PH, Masdeu JC, Nikumbh T, Soares BP, Thaker AA, Wang LL, Yasar S, Shih RY, Expert Panel on Neurological Imaging. ACR Appropriateness Criteria(R) Dementia: 2024 Update. J Am Coll Radiol. 2025 May; 22 (5S):S202-S233
    View PubMed
  10. Chen JJ, Kang Y, Gallagher D, Herrmann N, Survilla K, Vieira D, Mah E, Graham SJ, Kiss A, Black SE, Ramirez J, Oh P, Marzolini S, Zukotynski KA, Kuo PH, Lanctot KL. MRS demonstrates elevated brain glutathione in vascular mild cognitive impairment compared to cognitively normal coronary artery disease controls. Alzheimers Dement. 2025 May; 21 (5):e70230
    View PubMed
  11. Ivanidze J, Shih RY, Utukuri PS, Ajam AA, Auron M, Chang SM, Jordan JT, Kalnins A, Kuo PH, Ledbetter LN, Pannell JS, Pollock JM, Sheehan J, Soares BP, Soderlund KA, Wang LL, Burns J, Expert Panel on Neurological Imaging. ACR Appropriateness Criteria(R) Brain Tumors. J Am Coll Radiol. 2025 May; 22 (5S):S108-S135
    View PubMed
  12. Rabinovici GD, Knopman DS, Arbizu J, Benzinger TLS, Donohoe KJ, Hansson O, Herscovitch P, Kuo PH, Lingler JH, Minoshima S, Murray ME, Price JC, Salloway SP, Weber CJ, Carrillo MC, Johnson KA. Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup. Alzheimers Dement. 2025 Jan; 21(1):e14338. Epub 2025 Jan 08.
    View PubMed
  13. Kuo PH, Cella P, Chou YH, Arkhipenko A, Fisher JM. Optimal DaTQUANT Thresholds for Diagnostic Accuracy of Dementia with Lewy Bodies (DLB) and Parkinson's Disease (PD). Tomography. 2024 Oct 9; 10 (10):1608-1621 Epub 2024 Oct 09
    View PubMed
  14. Lowentritt BH, Jani AB, Helfand BT, Uchio EM, Morris MA, Michalski JM, Chau A, Davis P, Chapin BF, Schuster DM, SPOTLIGHT Study Group. Impact of Clinical Factors on (18)F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study. Adv Radiat Oncol. 2024 Aug; 9 (8):101532 Epub 2024 May 01
    View PubMed
  15. Kuo PH, Morris MJ, Hesterman J, Kendi AT, Rahbar K, Wei XX, Fang B, Adra N, Garje R, Michalski JM, Chi K, de Bono J, Fizazi K, Krause B, Sartor O, Tagawa ST, Ghebremariam S, Brackman M, Wong CC, Catafau AM, Benson T, Armstrong AJ, Herrmann K. Quantitative 68Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177Lu-PSMA-617 (VISION Trial). Radiology. 2024 Aug; 312(2):e233460.
    View PubMed
  16. Pells S, Zeraatkar N, Kalluri KS, Moore SC, May M, Furenlid LR, Kupinski MA, Kuo PH, King MA. Correction of multiplexing artefacts in multi-pinhole SPECT through temporal shuttering, de-multiplexing of projections, and alternating reconstruction. Phys Med Biol. 2024 Jun 6; 69 (12) Epub 2024 June 06
    View PubMed
  17. Wang LL, Thompson TA, Shih RY, Ajam AA, Bulsara K, Burns J, Davis MA, Ivanidze J, Kalnins A, Kuo PH, Ledbetter LN, Pannell JS, Pollock JM, Shakkottai VG, Shih RD, Soares BP, Soderlund KA, Utukuri PS, Woolsey S, Policeni B, Expert Panel on Neurological Imaging. ACR Appropriateness Criteria(R) Dizziness and Ataxia: 2023 Update. J Am Coll Radiol. 2024 Jun; 21 (6S):S100-S125
    View PubMed
  18. Kuo PH, Esposito G, Ulaner GA, Yoo D, Zukotynski K, Ravizzini GC, Penny R, Miller MP, Chau A, Davis P, Chapin BF, Schuster DM. SPOTLIGHT and LIGHTHOUSE study groups. Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies J Nucl Med. 2024.
  19. Kiess AP, O'Donoghue J, Uribe C, Bodei L, Hobbs RF, Hesterman J, Kesner AL, Sgouros G, RPT-TEC group. How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design. J Clin Oncol. 2024 May 20; 42 (15):1734-1737 Epub 2024 Mar 14
    View PubMed
  20. Jagust WJ, Mattay VS, Krainak DM, Wang SJ, Weidner LD, Hofling AA, Koo H, Hsieh P, Kuo PH, Farrar G, Marzella L. Quantitative Brain Amyloid PET. J Nucl Med. 2024 May 1; 65 (5):670-678 Epub 2024 May 01
    View PubMed
  21. Xhima K, Ottoy J, Gibson E, Zukotynski K, Scott C, Feliciano GJ, Adamo S, Kuo PH, Borrie MJ, Chertkow H, Frayne R, Laforce R Jr, Noseworthy MD, Prato FS, Sahlas DJ, Smith EE, Sossi V, Thiel A, Soucy JP, Tardif JC, Goubran M, Black SE, Ramirez J, Medical Imaging Trials Network of Canada (MITNEC). Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology. Alzheimers Dement. 2024 May; 20 (5):3687-3695 Epub 2024 Apr 04
    View PubMed
  22. Chen Z, Yuan NP, Taylor-Piliae RE, Rubio M, Yang Y, Horton AL, Robles D, Valenzuela R, Hu C, Roveda J, Kuo PH. The Wearable Sensors and Virtual Reality for Tai Chi and Qigong Intervention Research (We Sense Tai Chi): Feasibility Study The Journal of the International Society of Chinese Health Practices. 2024; 3(1).
  23. Kuo PH, Hermsen R, Penny R, Postema EJ. Quantitative and Qualitative Assessment of Urinary Activity of (18)F-Flotufolastat-PET/CT in Patients with Prostate Cancer: a Post Hoc Analysis of the LIGHTHOUSE and SPOTLIGHT Studies. Mol Imaging Biol. 2024 Feb; 26 (1):53-60 Epub 2023 Nov 06
    View PubMed
  24. Kuo PH, Covington MF, Lee DJ, Wong TZ, Pandit-Taskar N. Survey of Clinical Protocols for the Use of 177Lu-PSMA-617 in the United States Journal of Nuclear Medicine Technology. 2024.
  25. Mercer MK, Revels JW, Blacklock LC, Banks KP, Johnson LS, Lewis DH, Kuo PH, Wilson S, Elojeimy S. Practical Overview of (123)I-Ioflupane Imaging in Parkinsonian Syndromes. Radiographics. 2024 Feb; 44 (2):e230133
    View PubMed
  26. Romanchek GR, Shoop G, Kupinski MA, Kuo PH, King M, Furenlid LR, Abbaszadeh S. Investigation of Quantum Entanglement Information for ß?? Coincidences Bio-Algorithms and Med-Systems. 2024; 20:27-34.
  27. Losee MA, Seibyl JP, Kuo PH. Neurotheranostics: The Next Frontier for Health Span. J Nucl Med Technol. 2023 Dec 5; 51 (4):266-270 Epub 2023 Dec 05
    View PubMed
  28. Babiker HM, Kay MD, Stuehm C, Woodhead G, Kuo PH. A Pilot Study of F-18 Fluciclovine-PET/CT as a Diagnostic Tool for Bone Metastases in Patients With Castrate Resistant Prostate Adenocarcinoma and Correlative Analysis of Blood and Bone Molecular Testing (The FACT Study). Oncologist. 2023 Nov 02; 28(11):e1114-e1117.
    View PubMed
  29. Expert Panel on Musculoskeletal Imaging, Weissman BN, Palestro CJ, Fox MG, Bell AM, Blankenbaker DG, Frick MA, Jawetz ST, Kuo PH, Said N, Stensby JD, Subhas N, Tynus KM, Walker EA, Kransdorf MJ. ACR Appropriateness Criteria® Imaging After Total Hip Arthroplasty. J Am Coll Radiol. 2023 Nov; 20(11S):S413-S432.
    View PubMed
  30. Surasi DS, Eiber M, Maurer T, Preston MA, Helfand BT, Josephson D, Tewari AK, Somford DM, Rais-Bahrami S, Koontz BF, Bostrom PJ, Chau A, Davis P, Schuster DM, Chapin BF, LIGHTHOUSE Study Group. Diagnostic Performance and Safety of Positron Emission Tomography with (18)F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE). Eur Urol. 2023 Oct; 84 (4):361-370 Epub 2023 July 05
    View PubMed
  31. Kuo PH, Chen AY, Rodriguez RJ, Stuehm C, Chalasani P, Chen NK, Chou YH. Transcranial Magnetic Stimulation for the Treatment of Chemo Brain. Sensors (Basel). 2023 Sep 22; 23 (19) Epub 2023 Sept 22
    View PubMed
  32. Jani AB, Ravizzini GC, Gartrell BA, Siegel BA, Twardowski P, Saltzstein D, Fleming MT, Chau A, Davis P, Chapin BF, Schuster DM, SPOTLIGHT Study Group. Diagnostic Performance and Safety of (18)F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). J Urol. 2023 Aug; 210 (2):299-311 Epub 2023 Apr 26
    View PubMed
  33. Kuo PH, Yoo DC, Avery R, Seltzer M, Calais J, Nagarajah J, Weber WA, Fendler WP, Hofman MS, Krause BJ, Brackman M, Kpamegan E, Ghebremariam S, Benson T, Catafau AM, Kendi AT. A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy. J Nucl Med. 2023 Aug; 64(8):1259-1265. Epub 2023 May 25.
    View PubMed
  34. Ottoy J, Ozzoude M, Zukotynski K, Kang MS, Adamo S, Scott C, Ramirez J, Swardfager W, Lam B, Bhan A, Mojiri P, Kiss A, Strother S, Bocti C, Borrie M, Chertkow H, Frayne R, Hsiung R, Laforce RJ Jr, Noseworthy MD, Prato FS, Sahlas DJ, Smith EE, Kuo PH, Chad JA, Pasternak O, Sossi V, Thiel A, Soucy JP, Tardif JC, Black SE, Goubran M, Medical Imaging Trials Network of Canada (MITNEC) and Alzheimer's Disease Neuroimaging Initiative (ADNI). Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease. J Cereb Blood Flow Metab. 2023 Jun; 43 (6):921-936 Epub 2023 Jan 25
    View PubMed
  35. Seifert R, Telli T, Hadaschik B, Fendler WP, Kuo PH, Herrmann K. Is (18)F-FDG PET Needed to Assess (177)Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis. J Nucl Med. 2023 May; 64 (5):731-737 Epub 2022 Dec 15
    View PubMed
  36. Ottoy J, Ozzoude M, Zukotynski K, Adamo S, Scott C, Gaudet V, Ramirez J, Swardfager W, Cogo-Moreira H, Lam B, Bhan A, Mojiri P, Kang MS, Rabin JS, Kiss A, Strother S, Bocti C, Borrie M, Chertkow H, Frayne R, Hsiung R, Laforce RJ Jr, Noseworthy MD, Prato FS, Sahlas DJ, Smith EE, Kuo PH, Sossi V, Thiel A, Soucy JP, Tardif JC, Black SE, Goubran M, Medical Imaging Trial Network of Canada (MITNEC) and Alzheimer's Disease Neuroimaging Initiative (ADNI). Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET. Alzheimers Dement. 2023 Apr; 19 (4):1503-1517 Epub 2022 Sept 01
    View PubMed
  37. Auer B, Konik A, Fromme TJ, De Beenhouwer J, Kalluri KS, Lindsay C, Furenlid LR, Kuo PH, King MA. Mesh modeling of system geometry and anatomy phantoms for realistic GATE simulations and their inclusion in SPECT reconstruction. Phys Med Biol. 2023 Mar 29; 68 (7)
    View PubMed
  38. Seibyl JP, DuBois JM, Racine A, Collins J, Guo Q, Wooten D, Stage E, Cheng D, Gunn RN, Porat L, Whittington A, Kuo PH, Ichise M, Comley R, Martarello L, Salinas C. A Visual Interpretation Algorithm for Assessing Brain Tauopathy with (18)F-MK-6240 PET. J Nucl Med. 2023 Mar; 64 (3):444-451 Epub 2022 Sept 29
    View PubMed
  39. Healy A, Ho E, Kuo P, Zukotynski K. A brief overview of targeted radionuclide therapy trials in 2022. Front Nucl Med. 2023; 3:1169650 Epub 2023 June 23
    View PubMed
  40. Rabinovici, Knopman, Arbizu J, Benzinger, Donohoe K, Hansson O, Herscovitch P, Kuo P, Lingler JH, Minoshima S, Murray ME, Price JC, Salloway S, Weber CJ, Carrillo MC, Johnson KA. Updated Appropriate Use Criteria for Amyloid and Tau PET Alzheimer's Dement. 2023.
  41. Karbhari A, Mosessian S, Trivedi KH, Valla F Jr, Jacobson M, Truty MJ, Patnam NG, Simeone DM, Zan E, Brennan T, Chen H, Kuo PH, Herrmann K, Goenka AH. Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol. PLoS One. 2023; 18(11):e0294564. Epub 2023 Nov 27.
    View PubMed
  42. Seibyl JP, Kuo P. What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials? Neurology. 2022 Aug 16; 99 (7 Suppl 1):61-67
    View PubMed
  43. Warhadpande DS, Huo J, Libling WA, Stuehm C, Najafi B, Sherman S, Lei H, Roveda JM, Kuo PH. Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome. Sensors (Basel). 2022 Jul 5; 22 (13) Epub 2022 July 05
    View PubMed
  44. Eshghi A, Covington MF, Eshghi N, Kuo PH. Utility of PET to Appropriately Select Patients for PSMA-Targeted Theranostics. Clin Nucl Med. 2022 Jun 1; 47 (6):488-495 Epub 2022 Apr 05
    View PubMed
  45. Frazzitta AE, Kay MD, Warhadpande D, Kuo PH. Diagnosis of Pulmonary Embolism on 99mTc-Labeled Macroaggregated Albumin Lung Imaging After Hepatic Arterial Injection for Planning of Radioembolization. Clin Nucl Med. 2022 Mar 1; 47 (3):e246-e248
    View PubMed
  46. Neill M, Fisher JM, Brand C, Lei H, Sherman SJ, Chou YH, Kuo PH. Practical Application of DaTQUANT with Optimal Threshold for Diagnostic Accuracy of Dopamine Transporter SPECT. Tomography. 2021 Dec 18; 7 (4):980-989
    View PubMed
  47. Konik A, Zeraatkar N, Kalluri KS, Auer B, Fromme TJ, He Y, May M, Furenlid LR, Kuo PH, King MA. Improved Performance of a Multipinhole SPECT for DAT Imaging by Increasing Number of Pinholes at the Expense of Increased Multiplexing. IEEE Trans Radiat Plasma Med Sci. 2021 Nov; 5 (6):817-825 Epub 2020 Nov 03
    View PubMed
  48. Zeraatkar N, Kalluri KS, Auer B, May M, Richards RG, Furenlid LR, Kuo PH, King MA. Cerebral SPECT imaging with different acquisition schemes using varying levels of multiplexing versus sensitivity in an adaptive multi-pinhole brain-dedicated scanner. Biomed Phys Eng Express. 2021 Sep 22; 7 (6) Epub 2021 Sept 22
    View PubMed
  49. McBride A, Garcia AJ, Sanders LJ, Yiu K, Cranmer LD, Kuo PH, Kay M, Kraft AS. Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report. J Med Case Rep. 2021 Jul 24; 15 (1):400 Epub 2021 July 24
    View PubMed
  50. Bega D, Kuo PH, Chalkidou A, Grzeda MT, Macmillan T, Brand C, Sheikh ZH, Antonini A. Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis. NPJ Parkinsons Dis. 2021 May 24; 7 (1):43
    View PubMed
  51. Zeraatkar N, Auer B, Kalluri KS, May M, Momsen NC, Richards RG, Furenlid LR, Kuo PH, King MA. Improvement in sampling and modulation of multiplexing with temporal shuttering of adaptable apertures in a brain-dedicated multi-pinhole SPECT system. Phys Med Biol. 2021 Mar 2; 66 (6):065004 Epub 2021 Mar 02
    View PubMed
  52. Sawyer DM, Sawyer TW, Eshghi N, Hsu C, Hamilton RJ, Garland LL, Kuo PH. Pilot Study: Texture Analysis of PET Imaging Demonstrates Changes in (18)F-FDG Uptake of the Brain After Prophylactic Cranial Irradiation. J Nucl Med Technol. 2021 Mar; 49 (1):34-38 Epub 2020 Oct 05
    View PubMed
  53. Kay MD, Morris-Wiseman LF, Caskey J, Winegar BA, Kuo PH. 99mTc-Sestamibi Scintigraphy Reveals Parathyroid Adenoma Masquerading as Esophageal Diverticulum. Clin Nucl Med. 2021 Mar 01; 46(3):e159-e161.
    View PubMed
  54. Auer B, Zeraatkar N, Goding JC, Konik A, Fromme TJ, Kalluri KS, Furenlid LR, Kuo PH, King MA. Inclusion of quasi-vertex views in a brain-dedicated multi-pinhole SPECT system for improved imaging performance. Phys Med Biol. 2021 Jan 27; 66 (3):035007
    View PubMed
  55. Kuo PH. Cleaning the brain through turbulent glymphatic flow: The washing machine hypothesis. Lymphology. 2021; 54 (3):133-139
    View PubMed
  56. Cox T, Vance C, Daley S, Papendieck C, McGregor H, Kuo PH, Witte MH. Imaging of lymphatic dysplasia in Noonan syndrome: Case studies and historical atlas. Lymphology. 2021; 54 (1):23-40
    View PubMed
  57. Zeraatkar N, Kalluri KS, Auer B, Konik A, Fromme TJ, Furenlid LR, Kuo PH, King MA. Investigation of Axial and Angular Sampling in Multi-Detector Pinhole-SPECT Brain Imaging. IEEE Trans Med Imaging. 2020 Dec; 39 (12):4209-4224 Epub 2020 Nov 30
    View PubMed
  58. Mushtaq R, Kay MD, Steinmeyer L, Warhadpande D, Kuo PH. Pearls and Pitfalls of Quantitative Software Analysis of Dopamine Transporter SPECT. Clin Nucl Med. 2020 Nov; 45 (11):e469-e476
    View PubMed
  59. Schwartz FR, James O, Kuo PH, Witte MH, Koweek LM, Pabon-Ramos WM. Lymphatic Imaging: Current Noninvasive and Invasive Techniques. Semin Intervent Radiol. 2020 Aug; 37 (3):237-249 Epub 2020 July 31
    View PubMed
  60. McGregor H, Hill M, Kuo P, Woodhead G, Patel M. Same-Day Repeat Hepatopulmonary Shunt Measurement during Planning Angiography for Hepatic Radioembolization. J Vasc Interv Radiol. 2020 Jul; 31 (7):1069-1073 Epub 2020 May 18
    View PubMed
  61. Morbelli S, Esposito G, Arbizu J, Barthel H, Boellaard R, Bohnen NI, Brooks DJ, Darcourt J, Dickson JC, Douglas D, Drzezga A, Dubroff J, Ekmekcioglu O, Garibotto V, Herscovitch P, Kuo P, Lammertsma A, Pappata S, Penuelas I, Seibyl J, Semah F, Tossici-Bolt L, Van de Giessen E, Van Laere K, Varrone A, Wanner M, Zubal G, Law I. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. Eur J Nucl Med Mol Imaging. 2020 Jul; 47 (8):1885-1912 Epub 2020 May 09
    View PubMed
  62. Caskey JS, Kay MD, McMillan NA, Kuo PH, Woodhead GJ. Miscalculated Lung Shunt Fraction for Planning of Hepatic Radioembolization. J Nucl Med Technol. 2020 Jun; 48(2):184-186. Epub 2019 Dec 06.
    View PubMed
  63. Lundeen TF, Covington M, Krupinski EA, Avery R, Lei H, Sherman SJ, Kuo PH. Accuracy of Dopamine Transporter Imaging with (123)I-Ioflupane in Hispanic and Non-Hispanic Patients. J Nucl Med Technol. 2020 Jun; 48 (2):154-157 Epub 2019 Oct 11
    View PubMed
  64. Kay MD, Morris-Wiseman LF, Beazer A, Winegar BA, Kuo PH. Primary Nasolacrimal Duct Obstruction Visualized on (123)I Preablation Scan for Papillary Thyroid Carcinoma. J Nucl Med Technol. 2020 Mar; 48 (1):77-78 Epub 2019 Oct 11
    View PubMed
  65. Kay MD, Pariury HE, Perry A, Winegar BA, Kuo PH. Extracranial Metastases From Glioblastoma With Primitive Neuronal Components on FDG PET/CT. Clin Nucl Med. 2020 Mar; 45 (3):e162-e164
    View PubMed
  66. Erickson RP, Lai LW, Mustacich DJ, Bernas MJ, Kuo PH, Witte MH. Sex-limited penetrance of lymphedema to females with CELSR1 haploinsufficiency: A second family. Clin Genet. 2019 Nov; 96 (5):478-482 Epub 2019 Aug 23
    View PubMed
  67. Zukotynski K, Gaudet V, Kuo PH, Adamo S, Goubran M, Scott C, Bocti C, Borrie M, Chertkow H, Frayne R, Hsiung R, Laforce R Jr, Noseworthy MD, Prato FS, Sahlas DJ, Smith EE, Sossi V, Thiel A, Soucy JP, Tardif JC, Black SE. The Use of Random Forests to Classify Amyloid Brain PET. Clin Nucl Med. 2019 Oct; 44 (10):784-788
    View PubMed
  68. Banks KP, Peacock JG, Clemenshaw MN, Kuo PH. Optimizing the Diagnosis of Parkinsonian Syndromes With (123)I-Ioflupane Brain SPECT. AJR Am J Roentgenol. 2019 Aug; 213 (2):243-253 Epub 2019 Apr 17
    View PubMed
  69. Kuo PH, Eshghi N, Tinaz S, Blumenfeld H, Louis ED, Zubal G. Optimization of Parameters for Quantitative Analysis of (123)I-Ioflupane SPECT Images for Monitoring Progression of Parkinson Disease. J Nucl Med Technol. 2019 Mar; 47 (1):70-74 Epub 2018 Aug 23
    View PubMed
  70. Kuo PH, Barber BJ, Kylat RI, Klewer SE, Behan S, Lau-Braunhut S, Bernas MJ, Moedano L, Bedrick AD, Mustacich DJ, Witte MH. Whole-body lymphangioscintigraphy and SPECT/CT in children with lymphatic complications after surgery for complex congenital heart disease. Lymphology. 2019; 52 (4):157-165
    View PubMed
  71. Eshghi N, Garland LL, Choudhary G, Hsu CC, Eshghi A, Han J, Hamilton RJ, Krupinski E, Kuo PH. Regional Changes in Brain (18)F-FDG Uptake After Prophylactic Cranial Irradiation and Chemotherapy in Small Cell Lung Cancer May Reflect Functional Changes. J Nucl Med Technol. 2018 Dec; 46 (4):355-358 Epub 2018 Aug 03
    View PubMed
  72. Lundeen TF, Seibyl JP, Covington MF, Eshghi N, Kuo PH. Signs and Artifacts in Amyloid PET. Radiographics. 2018 Nov-Dec; 38 (7):2123-2133
    View PubMed
  73. Maarouf M, Curiel-Lewandrowski C, Daley S, Kuo P, Elquza E, Shi VY. Cutaneous erysipeloid metastasis of cholangiocarcinoma and evaluation by in vivo reflectance confocal microscopy. JAAD Case Rep. 2018 Oct; 4 (9):918-920 Epub 2018 Oct 10
    View PubMed
  74. Eshghi A, Klein R, Eshghi N, Kuo PH. (18)F-FDG PET/CT for the Evaluation of Primary Eosinophilic Granuloma of the Hypothalamus. J Nucl Med Technol. 2018 Sep; 46 (3):290-291 Epub 2018 May 03
    View PubMed
  75. Eshghi N, Garland LL, Nia E, Betancourt R, Krupinski E, Kuo PH. (18)F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer. J Nucl Med Technol. 2018 Sep; 46 (3):260-264 Epub 2018 Mar 29
    View PubMed
  76. Kuo PH, Stuehm C, Squire S, Johnson K. Meningeal Lymphatic Vessel Flow Runs Countercurrent to Venous Flow in the Superior Sagittal Sinus of the Human Brain. Tomography. 2018 Sep; 4 (3):99-104
    View PubMed
  77. Zukotynski K, Kuo PH, Mikulis D, Rosa-Neto P, Strafella AP, Subramaniam RM, Black SE. PET/CT of Dementia. AJR Am J Roentgenol. 2018 Aug; 211 (2):246-259 Epub 2018 June 27
    View PubMed
  78. Sawyer DM, Kuo PH. Top-Down Systematic Approach to Interpretation of FDG-PET for Dementia. Clin Nucl Med. 2018 Jun; 43 (6):e212-e214
    View PubMed
  79. Frankl JA, Bose S, Kuo PH. False-Positive Findings on Dopamine Transporter SPECT Due to Therapeutic Dextroamphetamine and Amphetamine. J Nucl Med Technol. 2018 Jun; 46 (2):149-150 Epub 2017 Dec 22
    View PubMed
  80. Manning MA, Kuo PH, Yeager AM. Disseminated coccidioidomycosis masquerading as recurrent lymphoma. BMJ Case Rep. 2018 May 26; 2018
    View PubMed
  81. Eshghi N, Lundeen TF, MacKinnon L, Avery R, Kuo PH. 18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab. Clin Nucl Med. 2018 May; 43 (5):e142-e144
    View PubMed
  82. Frankl J, Eshghi N, Lundeen TF, Kuo PH. Artifactual Hepatic Metastasis on FDG PET/CT Secondary to Cryoablation for Adrenal Metastasis. Clin Nucl Med. 2018 Feb; 43 (2):e46-e47
    View PubMed
  83. Eshghi N, Lundeen TF, Kuo PH. Dynamic Adaptation of Tumor Immune Response With Nivolumab Demonstrated by 18F-FDG PET/CT. Clin Nucl Med. 2018 Feb; 43 (2):114-116
    View PubMed
  84. Sawyer DM, Kuo PH. "Occipital Tunnel" Sign on FDG PET for Differentiating Dementias. Clin Nucl Med. 2018 Feb; 43 (2):e59-e61
    View PubMed
  85. Woodhead GJ, Avery RJ, Kuo PH. Atlas of Extraosseous Findings Detected by 18F-NaF PET/CT Bone Scan. Clin Nucl Med. 2017 Dec; 42 (12):930-938
    View PubMed
  86. Jones KM, Stuehm CA, Hsu CC, Kuo PH, Pagel MD, Randtke EA. Imaging Lung Cancer by Using Chemical Exchange Saturation Transfer MRI With Retrospective Respiration Gating. Tomography. 2017 Dec; 3 (4):201-210
    View PubMed
  87. Eshghi N, Christoforidis J, Kuo P. (18)F-FDG PET/CT for Monitoring Response to Therapy of Choroidal Metastasis. J Nucl Med Technol. 2017 Nov 10 [Epub ahead of print]
    View PubMed
  88. Nia ES, Garland LL, Eshghi N, Nia BB, Avery RJ, Kuo PH. Incidence of Brain Metastases on Follow-up (18)F-FDG PET/CT Scans of Non-Small Cell Lung Cancer Patients: Should We Include the Brain? J Nucl Med Technol. 2017 Sep; 45 (3):193-197 Epub 2017 July 13
    View PubMed
  89. Nia BB, Nia ES, Avery RJ, Kuo PH, Hennemeyer CT. Punctate Radiation Dermatitis of the Foot and Ankle Caused by Distal Embolization of 90Y Microspheres During Liver Directed Therapy. Clin Nucl Med. 2017 Sep; 42 (9):e422-e423
    View PubMed
  90. Jones KM, Randtke EA, Yoshimaru ES, Howison CM, Chalasani P, Klein RR, Chambers SK, Kuo PH, Pagel MD. Clinical Translation of Tumor Acidosis Measurements with AcidoCEST MRI. Mol Imaging Biol. 2017 Aug; 19 (4):617-625
    View PubMed
  91. Liu J, Cranmer L, Larsen BT, Kuo PH, Kopp LM. Recurrent Osteosarcoma Presenting as an Isolated Bone Marrow Relapse. J Pediatr Hematol Oncol. 2017 May; 39(4):302-305.
    View PubMed
  92. Covington MF, Curiel CN, Lattimore L, Avery RJ, Kuo PH. FDG-PET/CT for Monitoring Response of Melanoma to the Novel Oncolytic Viral Therapy Talimogene Laherparepvec. Clin Nucl Med. 2017 Feb; 42 (2):114-115
    View PubMed
  93. Kylat RI, Kuo PH, Bedrick AD, Witte MH. Neonatal Lymphedema from Thoracic Duct Obstruction Complicating Percutaneous Intravenous Central Catheterization. Lymphology. 2017; 50 (2):67-72
    View PubMed
  94. Covington MF, Choudhary G, Avery RJ, Kuo PH. Pitfalls in the Performance and Interpretation of Scintigraphic Imaging for Pleuroperitoneal Shunt. Clin Nucl Med. 2016 Nov; 41(11):858-861.
    View PubMed
  95. Covington MF, Choudhary G, Avery RJ, Krupinski EA, Kuo PH. Optimal Time Points for Scintigraphic Imaging of Pleuroperitoneal Shunts. Clin Nucl Med. 2016 Oct; 41 (10):766-8
    View PubMed
  96. Thai JN, Abidov A, Jie T, Krupinski EA, Kuo PH. Nuclear Myocardial Perfusion Imaging Versus Stress Echocardiography in the Preoperative Evaluation of Patients for Kidney Transplantation. J Nucl Med Technol. 2015 Sep; 43 (3):201-5 Epub 2015 June 25
    View PubMed
  97. Houghtelin AB, Kopp LM, Pelayo-Katsanis L, Kuo PH, Yeager AM, Katsanis E. Extramedullary Breast Relapse of Acute Lymphoblastic Leukemia Controlled with a Second Allogeneic/Autologous Hematopoietic Cell Transplant. J Adolesc Young Adult Oncol. 2015 Mar; 4 (1):50-3 Epub 2015 Mar 03
    View PubMed
  98. Chen LQ, Howison CM, Jeffery JJ, Robey IF, Kuo PH, Pagel MD. Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI. Magn Reson Med. 2014 Nov; 72 (5):1408-17 Epub 2013 Nov 26
    View PubMed
  99. Covington MF, Krupinski E, Avery RJ, Kuo PH. Classification schema of symptomatic enterogastric reflux utilizing sincalide augmentation on hepatobiliary scintigraphy. J Nucl Med Technol. 2014 Sep; 42(3):198-202. Epub 2014 Jul 17.
    View PubMed
  100. Kuo PH, Lei HH, Avery R, Krupinski EA, Bauer A, Sherman S, McMillan N, Seibyl J, Zubal GI. Evaluation of an Objective Striatal Analysis Program for Determining Laterality in Uptake of (1)(2)(3)I-Ioflupane SPECT Images: Comparison to Clinical Symptoms and to Visual Reads. J Nucl Med Technol. 2014 Jun; 42 (2):105-8 Epub 2014 Mar 13
    View PubMed
  101. Janicek AK, Avery RJ, Kuo PH. The pinwheel sign: artifact from head rotation during SPECT acquisition for dopamine transporter imaging. J Nucl Med Technol. 2014 Mar; 42 (1):75-6 Epub 2014 Jan 30
    View PubMed
  102. Hur S, Bauer A, McMillan N, Krupinski EA, Kuo PH. Optimizing the ventilation-perfusion lung scan for image quality and radiation exposure. J Nucl Med Technol. 2014 Mar; 42 (1):51-4 Epub 2014 Jan 30
    View PubMed
  103. Cummings JL, Fine MJ, Grachev ID, Jarecke CR, Johnson MK, Kuo PH, Schaecher KL, Oberdorf JA, Rezak M, Riley DE, Truong D. Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan). Am J Manag Care. 2014 Mar; 20 (5 Suppl):S97-109
    View PubMed
  104. Avery R, Kuo PH. 18F sodium fluoride PET/CT detects osseous metastases from breast cancer missed on FDG PET/CT with marrow rebound. Clin Nucl Med. 2013 Sep; 38 (9):746-8
    View PubMed
  105. Covington MF, McMillan NA, Avery RJ, Kuo PH. The semicolon sign: dopamine transporter imaging artifact from head tilt. J Nucl Med Technol. 2013 Jun; 41(2):105-7. Epub 2013 Mar 21.
    View PubMed
  106. Kuo PH, Avery R, Krupinski E, Lei H, Bauer A, Sherman S, McMillan N, Seibyl J, Zubal G. Receiver-operating-characteristic analysis of an automated program for analyzing striatal uptake of 123I-ioflupane SPECT images: calibration using visual reads. J Nucl Med Technol. 2013 Mar; 41 (1):26-31 Epub 2013 Feb 11
    View PubMed
  107. Anavy ND, Desai CS, Avery R, Kuo PH. Wandering kidney in dual-kidney transplant recipient presents a pitfall in the interpretation of renal scintigraphy. J Nucl Med Technol. 2012 Dec; 40 (4):275-7 Epub 2012 Sept 20
    View PubMed
  108. Nawas MT, Kubal WS, Kuo PH. Decreased cerebellar activity on FDG PET/CT secondary to diffuse idiopathic cerebellar calcification. Clin Nucl Med. 2012 Sep; 37 (9):906-7
    View PubMed
  109. Vakil V, Sung JJ, Piecychna M, Crawford JR, Kuo P, Abu-Alfa AK, Cowper SE, Bucala R, Gomer RH. Gadolinium-containing magnetic resonance image contrast agent promotes fibrocyte differentiation. J Magn Reson Imaging. 2009 Dec; 30 (6):1284-8
    View PubMed
  110. Weinreb JC, Kuo PH. Nephrogenic systemic fibrosis. Magn Reson Imaging Clin N Am. 2009 Feb; 17 (1):159-67
    View PubMed
  111. Kuo PH, Carlson KR, Christensen I, Girardi M, Heald PW. FDG-PET/CT for the evaluation of response to therapy of cutaneous T-cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trial. Mol Imaging Biol. 2008 Nov-Dec; 10 (6):306-14 Epub 2008 July 30
    View PubMed
  112. McEachen JC, Kuo PH. Male primary breast cancer found on FDG-PET/CT. Clin Nucl Med. 2008 Sep; 33 (9):630-2
    View PubMed
  113. Kuo PH, McClennan BL, Carlson K, Wilson LD, Edelson RL, Heald PW, Girardi M. FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma. Mol Imaging Biol. 2008 Mar-Apr; 10 (2):74-81 Epub 2008 Jan 15
    View PubMed
  114. Tomihama RT, McEachen JC, Kuo PH. Imaging of systemic mastocytosis by FDG-PET/CT demonstrates increased activity in cortical bone. Clin Nucl Med. 2008 Mar; 33 (3):220-3
    View PubMed
  115. Kuo PH. Gadolinium-containing MRI contrast agents: important variations on a theme for NSF. J Am Coll Radiol. 2008 Jan; 5 (1):29-35
    View PubMed
  116. Hathaway T, Subtil A, Kuo P, Foss F. Efficacy of denileukin diftitox in subcutaneous panniculitis-like T-cell lymphoma. Clin Lymphoma Myeloma. 2007 Sep; 7 (8):541-5
    View PubMed
  117. Kuo PH, Shin MS. Images in clinical medicine. Pulmonary and peritoneal ossification. N Engl J Med. 2007 Apr 26; 356 (17):e16
    View PubMed
  118. Shetty-Alva N, Novotny EJ, Shetty T, Kuo PH. Positron emission tomography in Rasmussen's encephalitis. Pediatr Neurol. 2007 Feb; 36 (2):112-4
    View PubMed
  119. Kuo PH, Monchamp T, Deol P. Imaging of inflammation in Graves' ophthalmopathy by positron emission tomography/computed tomography. Thyroid. 2006 Apr; 16 (4):419-20
    View PubMed
  120. Kuo PH, Spooner S, Deol P, Monchamp T. Metastatic inflammatory myofibroblastic tumor imaged by PET/CT. Clin Nucl Med. 2006 Feb; 31 (2):106-8
    View PubMed
  121. Kuo PH, Cooper DL, Cheng DW. Recurrence of lymphoma presenting as asymmetrically increased testicular activity on FDG-PET/CT. Semin Nucl Med. 2006 Jan; 36 (1):105-7
    View PubMed
  122. Kuo PH, Cheng DW. Artifactual spinal metastases imaged by PET/CT: a case report. J Nucl Med Technol. 2005 Dec; 33 (4):230-1
    View PubMed
  123. Kuo PH, Cheng DW, Sadar R. Diagnosis of septic joint in an immunosuppressed patient by twenty-four hour delayed imaging with Tc-99m HMPAO labeled white blood cell scan. Clin Nucl Med. 2005 Dec; 30 (12):808-9
    View PubMed
  124. Kuo PH, Nakamoto RK. Intragenic and intergenic suppression of the Escherichia coli ATP synthase subunit a mutation of Gly-213 to Asn: functional interactions between residues in the proton transport site. Biochem J. 2000 May 1; 347 Pt 3 (Pt 3):797-805
    View PubMed
  125. Kuo PH, Ketchum CJ, Nakamoto RK. Stability and functionality of cysteine-less F(0)F1 ATP synthase from Escherichia coli. FEBS Lett. 1998 Apr 17; 426 (2):217-20
    View PubMed
  126. Rye R, Kuo PH, Holland HD, New Collective Author. Atmospheric carbon dioxide concentrations before 2.2 billion years ago. Nature. 1995 Dec 7; 378 (6557):603-5
    View PubMed
PST-20599806